FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/07/090256 [Registered on: 07/07/2025] Trial Registered Prospectively
Last Modified On: 04/07/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Laser]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Lichen planus pigmentosus- To compare the efficacy between ND YAG laser Vs Intense pulse light 
Scientific Title of Study   A COMPARATIVE STUDY ON EFFICACY OF INTENSE PULSE LIGHT THERAPY WITH ORAL PULSE STERIODS VERSUS ND YAG NEODYMIUM DOPED YTTRIUM ALUMINUM GARNET LASER WITH ORAL PULSE STEROIDS IN FACIAL LICHEN PLANUS PIGMENTOSUS 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Meenalochini  
Designation  Postgraduate  
Affiliation  Chengalpet medical College and hospital  
Address  Department of DVL Chengalpet Medical College and Hospital Chengalpet

Kancheepuram
TAMIL NADU
603001
India 
Phone  9751469266  
Fax    
Email  lochini23.vasa.mani@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Jayakalyani 
Designation  Assistant professor  
Affiliation  Chengalpet medical College and hospital  
Address  Department of DVL Chengalpet Medical College and Hospital Chengalpet

Kancheepuram
TAMIL NADU
603001
India 
Phone  9600772668  
Fax    
Email  dermcliniccmch@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Jayakalyani 
Designation  Assistant professor  
Affiliation  Chengalpet medical College and hospital  
Address  Department of DVL Chengalpet Medical College and Hospital Chengalpet

Kancheepuram
TAMIL NADU
603001
India 
Phone  9600772668  
Fax    
Email  dermcliniccmch@gmail.com  
 
Source of Monetary or Material Support  
Department of DVL Chengalpattu Medical College and hospital Chengalpattu Kancheepuram TAMIL NADU 603001 India 
 
Primary Sponsor  
Name  Chengalpet Medical Colllege and Hospital Chengalpet  
Address  Department of DVL Chengalpattu Medical College and hospital Chengalpattu Kancheepuram TAMIL NADU 603001 India 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DrD Meenalochini   Chengalpet Medical College and Hospital, Chengalpet   ROOM NO 44, FLOOR NO 2,Dermatology OPD Kancheepuram TAMIL NADU
Kancheepuram
TAMIL NADU 
9751469266

lochini23.vasa.mani@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional ethics commitee,Chengalpattu Medical College  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L818||Other specified disorders of pigmentation,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Intense pulse light with Oral mini pulse with dexamethasone   Intense pulse light Pigment( 530nm ) and vascular(640nm) filters will be used with exposure time 12 msec, fluence of 28 mj/cm2 - every 4 weeks for 6 sessions Oral pulse therapy with T.Dexamethasone 5mg ORAL- 2 days a week [ preferably Saturday and Sunday] for 4 weeks then 4mg- 2 days a week for 2 weeks then 3mg- 2 days a week for 2 weeks then 2mg- 2 days a week for 2 weeks then 1mg- 2 days a week for 2 weeks Total duration of 12 weeks. 
Intervention  ND YAG laser with oral mini pulse with dexamethasone   ND-YAG 1064nm Q-switched ND-YAG laser : spot size 6 mm, 400mJ of energy , and frequency of 5Hz single pass is given over the lesions on the face . Total number of sessions is 6 which is done at 4 weeks apart. Oral steroid pulse therapy with T.Dexamethasone 5mg- 2 days a week for 4 weeks [ Preferably Saturday and Sunday] then 4mg- 2 days a week for 2 weeks then 3mg- 2 days a week for 2 weeks then 2mg- 2 days a week for 2 weeks then 1mg- 2 days a week for 2 weeks Total duration of 12 weeks. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  Patients of either sex above 18 years
Clinical criteria slate grey to violaceous to brown pigmentation
Histopathologically proven Lichen Planus Pigmentosus
Patients willing to give a written informed consent 
 
ExclusionCriteria 
Details  Pregnant and lactating women
Conditions mimicking LPP like Ashy dermatosis, Nevus of ota, macular amyloidosis, pigmented contact dermatitis, melasma
Active infection
Patients having photosensitivity / photosensitive dermatoses
Patients who are on immunosupressants, uncontrolled diabetes, Hypertension, active tuberculosis
 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1. Pre and post treatment clinical pictures to look for improvement in the pigmentation
2.Dermascopic assessement will also be done pre treatment and post treatment to look for dots and globular pattern, reticular pattern, hem like pattern, pseudo-reticular pattern
3. DPASI scoring system will be done
4. SKINDEX 16- for assessment of Emotional,functional and symptom domains of the patients

Interval 0 month, 6 months, 9 months 
0,6,9 months FOLLOW UP 
 
Secondary Outcome  
Outcome  TimePoints 
1. Erythema, irritation & burning sensation immediately after laser treatment
2. Post inflammatory depigmentation after completing 6 sessions of ND YAG laser or IPL therapy
3. If any patient in developing side Effects of oral steroids such as Hypertension, Diabetes & cushingoid features. Complete blood count ,Random blood glucose,blood pressure will be monitored every month 
1. Immediately after procedure
2. After completing every sessions of ND YAG or IPL
3. 3 months after completing all 6 sessions  
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Open to Recruitment 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Lichen Planus Pigmentosus  is a rare variant of Lichen Planus manifesting more commonly in middle aged patients of color and is a distint clinical entity commonly encountered in Indian population. It is characterised by insiduos onset of blue- brown macules over the face, sun exposed areas and flexure commonly. Rarely , generalised involvement will be there. Cosmetic disfigurement is the main concern among the patients. It has a chronic course and may take many months to years to fade off even with treatment.
 Treatment option includes Topical and Oral Steroids,Oral Isotretinoin, Topical Tacrolimus, oral Tranexamic acid ,Q-switched Nd-YAG . Very few case reports have been reported on treatment with IPL. Meire Brasil Parada et al reported IPL appears to be a promising, effective, and safe method in the aesthetic treatment of LPP. Swapnil Deepak Shah et al Q-switched Nd-YAG laser showed complete to near-complete resolution of pigment without much complications . So we are doing a comparative study among the two modalities

 
Close